{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:41:09Z","timestamp":1785174069180,"version":"3.55.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"Importance<\/jats:title>Diverse racial and ethnic representation in clinical trials has been limited, not representative of the US population, and the subject of pending US Food and Drug Administration guidance. Psoriasis presentation and disease burden can vary by skin pigmentation, race and ethnicity, and socioeconomic differences. Overall, there are limited primary data on clinical response, genetics, and quality of life in populations with psoriasis and skin of color (SoC). The Varying Skin Tones in Body and Scalp Psoriasis: Guselkumab Efficacy and Safety trial (VISIBLE) is underway and uses strategies aimed at addressing this persistent gap.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess the innovative strategies used in the VISIBLE trial to recruit and retain diverse participants in a randomized clinical trial of psoriasis in participants with SoC.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This was an ad hoc quality improvement assessment of participant recruitment and retention approaches used by the VISIBLE trial. VISIBLE enrolled and randomized 211 participants (mean [SD] age, 43 [13] years; 75 females [36%] and 136 males [64%]) with SoC and moderate to severe plaque psoriasis from August 2022 to March 2023 to evaluate guselkumab treatment. The self-identified race and ethnicity of the participants was: 1 American Indian\/Alaska Native (0.5%), 63 Asian (29.9%), 24 Black (11.4%), 94 Hispanic\/Latino (44.5%), 13 Middle Eastern (6.2%), 1 Pacific Islander\/Native Hawaiian (0.5%), 12 multiracial (5.7%), and 3 of other race and\/or ethnicity (1.4%). Using a combination of objective (colorimetry to determine Fitzpatrick skin type) and self-reported (race and ethnicity consistent with SoC) parameters, VISIBLE sought to broaden inclusion of participants from various backgrounds.<\/jats:p><\/jats:sec>Results<\/jats:title>Observed improvements were that participant enrollment occurred approximately 7 times faster than anticipated (vs historical recruitment data for psoriasis studies); 211 participants (100%) self-identified themselves as a race or ethnicity other than White; and more than 50% had skin tone in the darker half of the Fitzpatrick skin type spectrum (type IV-VI). Innovations implemented by VISIBLE were (1) assessment of the natural history of postinflammatory pigment alteration and improvements over time using combined objective colorimetry and clinician- and patient-reported outcomes; (2) evaluation of genetic and comorbidity biomarkers relevant to participants with SoC; (3) a diverse demographic-driven approach to site selection (emphasizing investigator and staff diversity and experience with populations with SoC); (4) provision of cultural competency training to enhance participant enrollment and retention; (5) collection of patient-reported outcomes data in participants\u2019 primary language; and (6) periodic, blinded central review and feedback on investigator efficacy scoring to promote consistency and accuracy in evaluating psoriasis in participants with SoC.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>VISIBLE is a unique study focused on addressing important knowledge and data gaps in populations of patients with psoriasis and SoC, with the goal of generating data to help improve clinical care and inform future best practices in diversity within dermatology research. The rapid study enrollment demonstrates that intentional and strategic approaches to clinical trial design and conduct can speed recruitment and bolster participation and retention of diverse populations in a dermatologic setting.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT05272150<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamadermatol.2024.5103","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:31:40Z","timestamp":1733949100000},"page":"256","source":"Crossref","is-referenced-by-count":15,"title":["Improving Diversity in a Novel Psoriasis Study"],"prefix":"10.1001","volume":"161","author":[{"given":"Andrew","family":"Alexis","sequence":"first","affiliation":[{"name":"Department of Dermatology, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"McMichael","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Vashi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Bhutani","sequence":"additional","affiliation":[{"name":"Synergy Dermatology, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian O.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Nashville Skin Comprehensive Dermatology Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jensen","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Choi","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Chan","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Alkousakis","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs LLC, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise N.","family":"Bronner","sequence":"additional","affiliation":[{"name":"Janssen Research & Development LLC, Spring House, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Park-Wyllie","sequence":"additional","affiliation":[{"name":"Janssen Inc, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Long","family":"Gao","sequence":"additional","affiliation":[{"name":"Janssen Research & Development LLC, Spring House, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl","family":"Grimes","sequence":"additional","affiliation":[{"name":"The Grimes Center for Medical and Aesthetic Dermatology, Vitiligo and Pigmentation Institute of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Shahriari","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Central Connecticut Dermatology, Cromwell"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Ontario, Canada"},{"name":"FACET Dermatology, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chesahna","family":"Kindred","sequence":"additional","affiliation":[{"name":"Kindred Hair & Skin Center, Columbia, Maryland"},{"name":"Department of Dermatology, Howard University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemal R.","family":"Desai","sequence":"additional","affiliation":[{"name":"Innovative Dermatology, Plano, Texas"},{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"doi240060r1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jamadermatol.2021.5596","article-title":"Assessment of changes in diversity in dermatology clinical trials between 2010-2015 and 2015-2020: a systematic review.","volume":"158","author":"Chen","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"12","key":"doi240060r2","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.2105\/AJPH.2011.300279","article-title":"Challenging assumptions about minority participation in US clinical research.","volume":"101","author":"Fisher","year":"2011","journal-title":"Am J Public Health"},{"issue":"3","key":"doi240060r3","doi-asserted-by":"publisher","first-page":"xiii","DOI":"10.1016\/j.det.2023.03.001","article-title":"Diagnosing skin diseases in skin of color.","volume":"41","author":"Taylor","year":"2023","journal-title":"Dermatol Clin"},{"issue":"4","key":"doi240060r6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/1054773812446510","article-title":"Making sense of skin color in clinical care.","volume":"21","author":"Everett","year":"2012","journal-title":"Clin Nurs Res"},{"issue":"6","key":"doi240060r7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI.","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"issue":"11","key":"doi240060r8","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s13555-022-00811-0","article-title":"Unmet need in people with psoriasis and skin of color in Canada and the United States.","volume":"12","author":"Yadav","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"doi240060r9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States.","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi240060r10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00403-022-02324-4","article-title":"Racial\/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review.","volume":"315","author":"Ferguson","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"doi240060r11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.12788\/cutis.0576","article-title":"Racial disparities in the diagnosis of psoriasis.","volume":"110","author":"Dickerson","year":"2022","journal-title":"Cutis"},{"issue":"5","key":"doi240060r12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cpcardiol.2018.11.002","article-title":"Increasing diversity in clinical trials: overcoming critical barriers.","volume":"44","author":"Clark","year":"2019","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"doi240060r13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11113-020-09631-6","article-title":"The critical role of racial\/ethnic data disaggregation for health equity.","volume":"40","author":"Kauh","year":"2021","journal-title":"Popul Res Policy Rev"},{"issue":"7","key":"doi240060r14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117940119","article-title":"Middle Eastern and North African Americans may not be perceived, nor perceive themselves, to be White.","volume":"119","author":"Maghbouleh","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"doi240060r15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40257-017-0332-7","article-title":"Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-White racial\/ethnic groups.","volume":"19","author":"Kaufman","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"doi240060r16","first-page":"16","article-title":"Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances.","volume":"7","author":"Alexis","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"issue":"8","key":"doi240060r17","first-page":"912","article-title":"Scalp psoriasis: an overview of the disease and available therapies.","volume":"9","author":"Crowley","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"doi240060r18","first-page":"309","article-title":"Quality of life in patients with scalp psoriasis.","volume":"150","author":"Zampieron","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"issue":"10","key":"doi240060r19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.36849\/JDD.7090","article-title":"Evolving concepts in psoriasis: special considerations for patients with skin of color, skin barrier dysfunction, and the role of adjunctive skin care.","volume":"21","author":"Alexis","year":"2022","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"doi240060r20","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jamadermatol.2013.6101","article-title":"Accuracy of self-report in assessing Fitzpatrick skin phototypes I through VI.","volume":"149","author":"Eilers","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi240060r21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.fsc.2016.08.011","article-title":"Skin color and pigmentation in ethnic skin.","volume":"25","author":"Visscher","year":"2017","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"5-6","key":"doi240060r22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1600-0781.1995.tb00169.x","article-title":"Relationship between skin color and cutaneous response to ultraviolet radiation in Thai.","volume":"11","author":"Leenutaphong","year":"1995","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"doi240060r23","first-page":"77","article-title":"Racial limitations of Fitzpatrick skin type.","volume":"105","author":"Ware","year":"2020","journal-title":"Cutis"},{"issue":"1","key":"doi240060r24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jid.2019.11.003","article-title":"Research techniques made simple: Cutaneous colorimetry: a reliable technique for objective skin color measurement.","volume":"140","author":"Ly","year":"2020","journal-title":"J Invest Dermatol"},{"key":"doi240060r25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/bjd.12529","article-title":"Variations in skin colour and the biological consequences of ultraviolet radiation exposure.","volume":"169","author":"Del Bino","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi240060r26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/09546634.2017.1392476","article-title":"Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.","volume":"29","author":"Saki","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"doi240060r27","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00403-022-02493-2","article-title":"Dermatologic conditions in skin of color compared to White patients: similarities, differences, and special considerations.","volume":"315","author":"Chatrath","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"doi240060r28","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamadermatol.2019.2063","article-title":"Assessment of Black patients\u2019 perception of their dermatology care.","volume":"155","author":"Gorbatenko-Roth","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"2","key":"doi240060r29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/bjd.20766","article-title":"Standardized clinical photography considerations in patients across skin tones.","volume":"186","author":"Oh","year":"2022","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi240060r30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.jaad.2020.02.025","article-title":"Characteristics of postinflammatory hyper- and hypopigmentation in patients with psoriasis: a survey study.","volume":"83","author":"Amico","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"doi240060r31","first-page":"20","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.","volume":"3","author":"Davis","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"doi240060r32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jaad.2021.02.010","article-title":"Measurement and prediction of the severity of postinflammatory dyspigmentation after resolution of psoriatic plaques in patients treated with biologic therapy.","volume":"86","author":"Chiu","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"doi240060r33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.mpmed.2021.04.010","article-title":"Skin pigmentation.","volume":"49","author":"Lakhan","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"doi240060r34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2310\/7750.2009.08077","article-title":"Postinflammatory hyperpigmentation.","volume":"13","author":"Taylor","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"doi240060r35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3899\/jrheum.120237","article-title":"Metabolic syndrome in patients with psoriatic disease.","volume":"89","author":"Gelfand","year":"2012","journal-title":"J Rheumatol Suppl"},{"issue":"1","key":"doi240060r36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu12010015","article-title":"Ethnicity and metabolic syndrome: Implications for assessment, management and prevention.","volume":"12","author":"Lear","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"doi240060r37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","article-title":"Vitamin D and its role in psoriasis: an overview of the dermatologist and nutritionist.","volume":"18","author":"Barrea","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"issue":"12","key":"doi240060r38","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1039\/c5pp00168d","article-title":"A systematic review of the influence of skin pigmentation on changes in the concentrations of vitamin D and 25-hydroxyvitamin D in plasma\/serum following experimental UV irradiation.","volume":"14","author":"Xiang","year":"2015","journal-title":"Photochem Photobiol Sci"},{"key":"doi240060r39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/1471-2458-14-597","article-title":"Skin pigmentation, sun exposure and vitamin D levels in children of the Avon Longitudinal Study of Parents and Children.","volume":"14","author":"Bonilla","year":"2014","journal-title":"BMC Public Health"},{"issue":"3","key":"doi240060r40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000354750","article-title":"Skin color is relevant to vitamin D synthesis.","volume":"227","author":"Libon","year":"2013","journal-title":"Dermatology"},{"issue":"5","key":"doi240060r41","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00403-022-02507-z","article-title":"Racial disparities in dermatology.","volume":"315","author":"Narla","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"doi240060r42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/cncr.33905","article-title":"Strategies to improve diversity, equity, and inclusion in clinical trials.","volume":"128","author":"Kahn","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"doi240060r43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.18865\/ed.32.1.61","article-title":"Advancing inclusive research: establishing collaborative strategies to improve diversity in clinical trials.","volume":"32","author":"Garrick","year":"2022","journal-title":"Ethn Dis"},{"issue":"8","key":"doi240060r44","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States.","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol"},{"key":"doi240060r4","unstructured":"Taylor? SC, Kyei? A. Defining Skin of Color. In: Kelly AP, Taylor SC, Lim HW, Serrano AMA, eds. Taylor and Kelly\u2019s Dermatology for Skin of Color. McGraw-Hill; 2016. Accessed November 6, 2024. https:\/\/accessmedicine.mhmedical.com\/book.aspx?bookID=2585"},{"key":"doi240060r5","unstructured":"United States Food and Drug Administration. Collection of race and ethnicity data in clinical trials. 2016. Accessed November 6, 2024. https:\/\/www.fda.gov\/media\/75453\/download"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2827346\/jamadermatology_alexis_2024_oi_240060_1741115882.98759.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T16:04:47Z","timestamp":1742400287000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2827346"}},"subtitle":["VISIBLE as a Framework for Clinical Trial Quality Improvement"],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.5103","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}